Search research articles
Contact Us
Filters
Showing results (31-40 of 81) with videos related to
Page
of 9
Sort By:
Transplantation and Cellular Therapy
|
May 11, 2026
Infections in the first 30-days after CAR-T therapy in Patients Not Receiving Fluoroquinolone Prophylaxis
Gemma K Reynolds, Mark R Dowling, Jose Valencia-Klug, et al.
British Journal of Haematology
|
July 12, 2022
Predictors of early mortality in multiple myeloma: Results from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR)
Zoe McQuilten, Cameron Wellard, Elizabeth Moore, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 5, 2025
Real-World Comparison of Treatment Outcomes for Multiple Myeloma in Elderly Transplant Ineligible Patients Receiving First-Line VRd, Rd and VCd: Results From the Australian and New Zealand Myeloma and Related Diseases Registry
Sarah Zhao, Cameron Wellard, Elizabeth M Moore, et al.
Haematologica
|
October 14, 2011
Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1
Silvia C W Ling, Edwin K K Lau, Ammira Al-Shabeeb, et al.
Internal Medicine Journal
|
August 5, 2025
Management of patients with newly diagnosed multiple myeloma who are eligible for autologous stem cell transplantation: position statement of the Medical and Scientific Advisory Group of Myeloma Australia
Georgia McCaughan, Hayley Beer, Christian Bryant, et al.
Internal Medicine Journal
|
December 8, 2023
Sickle cell disease in Australia: a snapshot from the Australian Haemoglobinopathy Registry
Anna Nelson, P Joy Ho, Helen Haysom, et al.
Internal Medicine Journal
|
January 8, 2026
Treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group
Shirlene Sim, Georgia McCaughan, Andrew Zannettino, et al.
Blood
|
March 2, 2010
Clonal expansions of cytotoxic T cells exist in the blood of patients with Waldenstrom macroglobulinemia but exhibit anergic properties and are eliminated by nucleoside analogue therapy
Jia Li, Daniel M-Y Sze, Ross D Brown, et al.
Immunology and Cell Biology
|
January 22, 2016
A CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subset
Christian Bryant, Phillip D Fromm, Fiona Kupresanin, et al.
Internal Medicine Journal
|
May 6, 2025
Economic burden of sickle cell disease in Australia
Steve Nwokeocha, Helen E Haysom, Cameron Wellard, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 81) with videos related to
Sort By:
Page
of 9
Transplantation and Cellular Therapy
|
May 11, 2026
Infections in the first 30-days after CAR-T therapy in Patients Not Receiving Fluoroquinolone Prophylaxis
Gemma K Reynolds, Mark R Dowling, Jose Valencia-Klug, et al.
British Journal of Haematology
|
July 12, 2022
Predictors of early mortality in multiple myeloma: Results from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR)
Zoe McQuilten, Cameron Wellard, Elizabeth Moore, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 5, 2025
Real-World Comparison of Treatment Outcomes for Multiple Myeloma in Elderly Transplant Ineligible Patients Receiving First-Line VRd, Rd and VCd: Results From the Australian and New Zealand Myeloma and Related Diseases Registry
Sarah Zhao, Cameron Wellard, Elizabeth M Moore, et al.
Haematologica
|
October 14, 2011
Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1
Silvia C W Ling, Edwin K K Lau, Ammira Al-Shabeeb, et al.
Internal Medicine Journal
|
August 5, 2025
Management of patients with newly diagnosed multiple myeloma who are eligible for autologous stem cell transplantation: position statement of the Medical and Scientific Advisory Group of Myeloma Australia
Georgia McCaughan, Hayley Beer, Christian Bryant, et al.
Internal Medicine Journal
|
December 8, 2023
Sickle cell disease in Australia: a snapshot from the Australian Haemoglobinopathy Registry
Anna Nelson, P Joy Ho, Helen Haysom, et al.
Internal Medicine Journal
|
January 8, 2026
Treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group
Shirlene Sim, Georgia McCaughan, Andrew Zannettino, et al.
Blood
|
March 2, 2010
Clonal expansions of cytotoxic T cells exist in the blood of patients with Waldenstrom macroglobulinemia but exhibit anergic properties and are eliminated by nucleoside analogue therapy
Jia Li, Daniel M-Y Sze, Ross D Brown, et al.
Immunology and Cell Biology
|
January 22, 2016
A CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subset
Christian Bryant, Phillip D Fromm, Fiona Kupresanin, et al.
Internal Medicine Journal
|
May 6, 2025
Economic burden of sickle cell disease in Australia
Steve Nwokeocha, Helen E Haysom, Cameron Wellard, et al.
Page
of 9